SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing

被引:114
作者
Zahler, AM
Damgaard, CK
Kjems, J
Caputi, M [1 ]
机构
[1] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL 33431 USA
[2] Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA
[3] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Sinsheimer Labs, Santa Cruz, CA 95064 USA
[4] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1074/jbc.M312743200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Splicing of the human immunodeficiency virus, type 1, primary transcript is highly regulated. Maintaining the proper equilibrium among spliced, unspliced, and partially spliced isoforms is essential for the replication of the virus. Here we characterize a complex cis-acting element located in tat exon 2 that is required for the splicing regulation of the upstream intron. An exonic splicing enhancer (ESE) and an exonic splicing silencer (ESS) are both located within the regulatory element. Heterogeneous nuclear ribonucleoprotein ( hnRNP) A/B proteins bind the ESS to repress splicing, whereas the SR protein SC35 binds the ESE to activate it. We show that the SC35 and the hnRNP A1 binding sites overlap within the juxtaposed ESE/ESS. We propose that hnRNP A1 binding to the ESS inhibits splicing of the upstream intron by directly masking the SC35 binding site.
引用
收藏
页码:10077 / 10084
页数:8
相关论文
共 43 条
[1]   PRESENCE OF NEGATIVE AND POSITIVE CIS-ACTING RNA SPLICING ELEMENTS WITHIN AND FLANKING THE FIRST TAT CODING EXON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
AMENDT, BA ;
HESSLEIN, D ;
CHANG, LJ ;
STOLTZFUS, CM .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) :3960-3970
[2]  
AMENDT BA, 1995, MOL CELL BIOL, V15, P4606
[3]   RNA splicing at human immunodeficiency virus type 1 3′ splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element [J].
Bilodeau, PS ;
Domsic, JK ;
Mayeda, A ;
Krainer, AR ;
Stoltzfus, CM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8487-8497
[4]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[5]   RNA-BINDING SPECIFICITY OF HNRNP A1 - SIGNIFICANCE OF HNRNP A1 HIGH-AFFINITY BINDING-SITES IN PRE-MESSENGER-RNA SPLICING [J].
BURD, CG ;
DREYFUSS, G .
EMBO JOURNAL, 1994, 13 (05) :1197-1204
[6]   hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing [J].
Caputi, M ;
Mayeda, A ;
Krainer, AR ;
Zahler, AM .
EMBO JOURNAL, 1999, 18 (14) :4060-4067
[7]   A NOVEL BIPARTITE SPLICING ENHANCER MODULATES THE DIFFERENTIAL PROCESSING OF THE HUMAN FIBRONECTIN EDA EXON [J].
CAPUTI, M ;
CASARI, G ;
GUENZI, S ;
TAGLIABUE, R ;
SIDOLI, A ;
MELO, CA ;
BARALLE, FE .
NUCLEIC ACIDS RESEARCH, 1994, 22 (06) :1018-1022
[8]   The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers [J].
Cavaloc, Y ;
Bourgeois, CF ;
Kister, L ;
Stévenin, J .
RNA, 1999, 5 (03) :468-483
[9]   Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat β-tropomyosin gene [J].
Chen, CD ;
Kobayashi, R ;
Helfman, DM .
GENES & DEVELOPMENT, 1999, 13 (05) :593-606
[10]   hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure [J].
Damgaard, CK ;
Tange, TO ;
Kjems, J .
RNA, 2002, 8 (11) :1401-1415